The DEA Responds to ADHD Patients Concerns—But Misses the Point Entirely
How the Agency’s Response to Hundreds of Comments on Federal Register Docket #2025-21509 Reveals a Fundamental Misunderstanding of the ADHD Medication Crisis By Marilynn Monroe In January 2026, after receiving over 5,000 public comments on docket #2025-21509 regarding 2026 Aggregate Production Quotas (APQs), the Drug Enforcement Administration issued its response. Among these public comments, hundreds […]
The DEA Responds to ADHD Patients Concerns—But Misses the Point Entirely Read More »





